Achilles Therapeutics Plc (NQ: ACHL )
0.8260 -0.0241 (-2.83%) Streaming Delayed Price Updated: 3:58 PM EST, Nov 30, 2023 Add to My Watchlist
All News about Achilles Therapeutics Plc
Secarna Pharmaceuticals and Achilles Therapeutics Sign Research, Option and License Agreement to Develop Optimized T Cell Therapies
November 10, 2021
- Secarna's LNAplusTM ASOs have the potential to optimize personalized T cell therapies being developed by Achilles - Secarna's industry-leading antisense oligonucleotide (ASO) platform LNAplusTM...